Lexapro (Escitalopram Oxalate)

Escitalopram blocks the serotonin transporter on presynaptic nerve cells, preventing reabsorption of serotonin. This raises serotonin levels in the synaptic gap, enhancing serotonergic signaling, which is linked to improved mood and reduced anxiety.

The appropriate dose of Lexapro is determined by a qualified prescriber based on the individual’s clinical condition, response, and tolerability. Physicians typically start with a low dose and may adjust it as needed, following current clinical guidelines.

Safety data for escitalopram in pregnancy and lactation are limited. Prescribers weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss all concerns with their healthcare provider before starting Lexapro.

To request Lexapro, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lexapro is an SSRI, a class known for a favorable side‑effect profile compared with older antidepressants such as tricyclics or MAO inhibitors. Compared with other SSRIs, escitalopram is the S‑enantiomer of citalopram and often requires a lower dose to achieve similar efficacy, which may reduce certain adverse effects.

Lexapro should be stored at room temperature, below 25 °C (77 °F). Keep the tablets in the original packaging, protect them from moisture and direct light, and store them out of reach of children.

Lexapro is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.

The most serious risks include the potential for serotonin syndrome, especially when combined with other serotonergic drugs, and the emergence of suicidal thoughts or behaviors, particularly in younger adults. Severe allergic reactions and cardiac arrhythmias in susceptible individuals are also rare but critical concerns.

Lexapro is contraindicated in individuals who have a known hypersensitivity to escitalopram or any component of the formulation, and in patients currently taking monoamine oxidase inhibitors (MAOIs). Caution is advised for those with a history of bipolar disorder, uncontrolled narrow‑angle glaucoma, or significant cardiac conduction abnormalities.